GLP-1 medications, their effect on bariatrics and cautions for people seeking weight loss without surgery
Glucagon-like peptide 1 receptor agonists, more commonly known as GLP-1 medications, have dominated headlines for their success in managing blood sugar levels and drastically reducing weight. Between new clinical trial results and a boom in celebrity usage, the popularity of the medications increased drastically over the past two years.
Agents like semaglutide show promise for treatment of substance use disorders. Inaccessibility of GLP-1 agonists due to high ...
Brands like Kourtney Kardashian's Lemme are claiming to provide the same benefits as GLP-1 medications like Ozempic, Wegovy, ...
Kourtney Kardashian’s vitamin and supplement brand Lemme launched GLP-1 daily capsules in mid-September. For $90 a month, the ...
GlobalData on MSN1d
Social media algorithms are driving the the GLP-1 drugs boomGLP-1 RAs are being recommended on social media, raising questions about who can see the content and what the effects might ...
Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...
Ilant estimates that behavioral therapy can help many people lose up to 5% of their weight, anti-obesity medications can help ...
The new Lemme GLP-1 Daily Capsules are being called an "Ozempic alternative." But do they really work — and if so, at what ...
NBC 7 dives deep into the explosive popularity of the medications and explores both the life-changing benefits and the ...
"There is a clear association between the use of GLPs and increased risks of food retention during upper endoscopy," Mathur ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback